AAAAAA

   
Results: 1-11 |
Results: 11
COMBINATION THERAPY IN RECENT-ONSET RHEUMATOID-ARTHRITIS - A RANDOMIZED DOUBLE-BLIND TRIAL OF THE ADDITION OF LOW-DOSE CYCLOSPORINE TO PATIENTS TREATED WITH LOW-DOSE CHLOROQUINE
Authors: VANDENBORNE BEEM LANDEWE RBM THE HSG RIETVELD JH ZWINDERMAN AH BRUYN GAW BREEDVELD FC DIJKMANS BAC
Citation: Beem. Vandenborne et al., COMBINATION THERAPY IN RECENT-ONSET RHEUMATOID-ARTHRITIS - A RANDOMIZED DOUBLE-BLIND TRIAL OF THE ADDITION OF LOW-DOSE CYCLOSPORINE TO PATIENTS TREATED WITH LOW-DOSE CHLOROQUINE, Journal of rheumatology, 25(8), 1998, pp. 1493-1498
ANDROGENIZING EFFECTS OF LOW-DOSE CYCLOSPORINE IN MALE-PATIENTS WITH EARLY RA
Authors: GILTAY EJ VANDENBORNE BEEM VANSCHAARDENBURG D GOOREN LJG POPPSNIJDERS C BLANKENSTEIN MA DIJKMANS BAC
Citation: Ej. Giltay et al., ANDROGENIZING EFFECTS OF LOW-DOSE CYCLOSPORINE IN MALE-PATIENTS WITH EARLY RA, British journal of rheumatology, 37(4), 1998, pp. 470-472
CYCLOSPORINE-A THERAPY IN RHEUMATOID-ARTHRITIS - ONLY STRICT APPLICATION OF THE GUIDELINES FOR SAFE USE CAN PREVENT IRREVERSIBLE RENAL-FUNCTION LOSS
Authors: VANDENBORNE BEEM LANDEWE RBM THE HSG BREEDVELD FC DIJKMANS BAC
Citation: Beem. Vandenborne et al., CYCLOSPORINE-A THERAPY IN RHEUMATOID-ARTHRITIS - ONLY STRICT APPLICATION OF THE GUIDELINES FOR SAFE USE CAN PREVENT IRREVERSIBLE RENAL-FUNCTION LOSS, Arthritis and rheumatism, 41(9), 1998, pp. 729-729
DOES LONG-TERM CYCLOSPORINE-A TREATMENT IN RHEUMATOID-ARTHRITIS PROTECT AGAINST CANCER
Authors: VANDENBORNE BEEM LANDEWE RBM BREEDVELD FC MOENS HJB DIJKMANS BAC
Citation: Beem. Vandenborne et al., DOES LONG-TERM CYCLOSPORINE-A TREATMENT IN RHEUMATOID-ARTHRITIS PROTECT AGAINST CANCER, Arthritis and rheumatism, 41(9), 1998, pp. 730-730
NO INCREASED RISK OF MALIGNANCIES AND MORTALITY IN CYCLOSPORINE A-TREATED PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: VANDENBORNE BEEM LANDEWE RBM HOUKES I SCHILD F VANDERHEYDEN PCW HAZES JMW VANDENBROUCKE JP ZWINDERMAN AH THE HSG BREEDVELD FC MOENS HJB KLUIN PM DIJKMANS BAC
Citation: Beem. Vandenborne et al., NO INCREASED RISK OF MALIGNANCIES AND MORTALITY IN CYCLOSPORINE A-TREATED PATIENTS WITH RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 41(11), 1998, pp. 1930-1937
CHLOROQUINE AND CYTOKINES - REPLY
Authors: VANDENBORNE BEEM DIJKMANS BAC DEROOIJ HH LECESSIE S VERWEIJ CL
Citation: Beem. Vandenborne et al., CHLOROQUINE AND CYTOKINES - REPLY, Journal of rheumatology, 24(10), 1997, pp. 2051-2052
CHLOROQUINE AND HYDROXYCHLOROQUINE EQUALLY AFFECT TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-6, AND INTERFERON-GAMMA PRODUCTION BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS
Authors: VANDENBORNE BEEM DIJKMANS BAC DEROOIJ HH LECESSIE S VERWEIJ CL
Citation: Beem. Vandenborne et al., CHLOROQUINE AND HYDROXYCHLOROQUINE EQUALLY AFFECT TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-6, AND INTERFERON-GAMMA PRODUCTION BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS, Journal of rheumatology, 24(1), 1997, pp. 55-60
NO INCREASED RISK OF MALIGNANCIES AND MORTALITY IN CYCLOSPORINE-A TREATED RHEUMATOID-ARTHRITIS PATIENTS
Authors: VANDENBORNE BEEM LANDEWE RBM HOUKES I SCHILD F VANDERHEYDEN PCW HAZES JMW VANDENBROUCKE JP ZWINDERMAN AH THE HSG BREEDVELD FC MOENS HJB KLUYN P DIJKMANS BAC
Citation: Beem. Vandenborne et al., NO INCREASED RISK OF MALIGNANCIES AND MORTALITY IN CYCLOSPORINE-A TREATED RHEUMATOID-ARTHRITIS PATIENTS, Arthritis and rheumatism, 40(9), 1997, pp. 985-985
CHLOROQUINE COMBINED WITH CYCLOSPORINE IN RHEUMATOID-ARTHRITIS - MORETHAN THE ADDITION OF 2 DRUGS ALONE
Authors: DIJKMANS BAC VANDENBORNE BEEM LANDEWE RBM MILTENBURG AMM VERWEIJ CL BREEDVELD FC
Citation: Bac. Dijkmans et al., CHLOROQUINE COMBINED WITH CYCLOSPORINE IN RHEUMATOID-ARTHRITIS - MORETHAN THE ADDITION OF 2 DRUGS ALONE, Journal of rheumatology, 23, 1996, pp. 61-63
LOW-DOSE CYCLOSPORINE IN EARLY RHEUMATOID-ARTHRITIS - EFFECTIVE AND SAFE AFTER 2 YEARS OF THERAPY WHEN COMPARED WITH CHLOROQUINE
Authors: VANDENBORNE BEEM LANDEWE RBM THE HSG BREEDVELD FC DIJKMANS BAC
Citation: Beem. Vandenborne et al., LOW-DOSE CYCLOSPORINE IN EARLY RHEUMATOID-ARTHRITIS - EFFECTIVE AND SAFE AFTER 2 YEARS OF THERAPY WHEN COMPARED WITH CHLOROQUINE, Scandinavian journal of rheumatology, 25(5), 1996, pp. 307-316
RELATIVE BIOAVAILABILITY OF A NEW ORAL FORM OF CYCLOSPORINE-A IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: VANDENBORNE BEEM LANDEWE RBM THE HSG MATTIE H BREEDVELD FC DIJKMANS BAC
Citation: Beem. Vandenborne et al., RELATIVE BIOAVAILABILITY OF A NEW ORAL FORM OF CYCLOSPORINE-A IN PATIENTS WITH RHEUMATOID-ARTHRITIS, British journal of clinical pharmacology, 39(2), 1995, pp. 172-175
Risultati: 1-11 |